| Filing Date |
Description |
| 2009-06-12 |
On June 12, 2009, Genaera Corporation (the "Company") announced that its Board of Directors voted to dissolve the Company. At a Special Meeting of Stockholders held on June 4, 2009, the Company's stockholders approved a Plan of Complete Liquidation a ... |
| 2009-06-10 |
On June 5, 2009, Genaera Corporation (the "Company") issued a press release announcing the results of its Special Meeting of Stockholders held June 4, 2009. A copy of the Company's press release is attached hereto as Exhibit 99.1 and is incorporated ... |
| 2009-04-29 |
On April 28, 2009, Genaera Corporation, (the "Company') issued a press release announcing that its Board of Directors has determined to liquidate the Company's assets and to dissolve the Company. The Company's Board of Directors has approved a Plan o ... |
| 2009-04-28 |
On April 27, 2009, Genaera Corporation (the "Company") and Michael J. Gast, M.D., Ph.D., the Company's former Executive Vice President and Chief Medical Officer, entered into a consulting agreement pursuant to which Dr. Gast will act as a consultant ... |
| 2009-04-03 |
On April 1, 2009, Genaera Corporation (the "Company") and Henry R. Wolfe, Ph.D., the Company's current Executive Vice President and Chief Scientific Officer, entered into a consulting agreement pursuant to which Dr. Wolfe will act as a consultant to ... |
